radiolabeled HPMA copolymer conjugates (Molecular Insight)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameradiolabeled HPMA copolymer conjugates (Molecular Insight)

Drug Alias Name188Re-HPMA copolymer-RGE4C (Molecular Insight)210Po-labelled RGD4C99mTc-HPMA copolymer-RGD4C (Molecular Insight)99mTc-HPMA copolymer-RGE4C (Molecular Insight)188Re-HPMA copolymer-RGD4C +[7]

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radioactive diagnostic agent

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsAngiogenesis disorder

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMolecular Insight Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMolecular Insight Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsAngiogenesis disorder

Other Information

ATC CodeN/A